The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Customer Care direct line: +44 (0)1256 315 999
Medical Information Fax: +44 (0)1256 775 569
Need to contact this company?
Patient Information Leaflet last updated on the eMC: 19/10/2009
PIL Forsteo 20 micrograms/80 microlitres, solution for injection, in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/10/2009 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 02/07/2009 and displayed until 19/10/2009
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 20/03/2009 and displayed until 02/07/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 30/04/2008 and displayed until 20/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Changes to therapeutic indications
Updated on 05/12/2007 and displayed until 30/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 30/08/2007 and displayed until 05/12/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 20/08/2007 and displayed until 30/08/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to instructions about overdose
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Change to date of revision
Updated on 19/12/2005 and displayed until 20/08/2007
Reasons for adding or updating:
  • No reasons supplied
Updated on 23/07/2003 and displayed until 19/12/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  teriparatide


Return to the top of the page

© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk